Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Capsaicin (Standard)

Capsaicin (Standard) is the analytical standard of Capsaicin. This product is intended for research and analytical applications. Capsaicin ((E) -Capsaicin), an active component of chili peppers, is a TRPV1 agonist. Capsaicin has pain relief, antioxidant, anti-inflammatory and anti-cancer effects[1][2].

Product Specifications

CAS Number

[404-86-4]

Product Name Alternative

(E) -Capsaicin (Standard)

UNSPSC

12352005

Hazard Statement

H300, H315, H317, H318, H334, H335

Target

Apoptosis; Autophagy; Endogenous Metabolite; Reference Standards; TRP Channel

Type

Reference Standards

Related Pathways

Apoptosis; Autophagy; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/capsaicin-standard.html

Purity

99.38

Smiles

CC(C)/C=C/CCCCC(NCC1=CC=C(O)C(OC)=C1)=O

Molecular Formula

C18H27NO3

Molecular Weight

305.41

Precautions

H300, H315, H317, H318, H334, H335

Shipping Conditions

Room Temperature

Storage Conditions

4°C, sealed storage, away from light and moisture

Scientific Category

Reference Standards

Clinical Information

Launched

Citation 01

Neurosci Bull. 2025 Oct 30.|ACS Omega. 2025 Aug 21;10 (34) :39192-39202.|Acta Pharmacol Sin. 2023 Apr;44 (4) :766-779.|Acta Pharmacol Sin. 2024 Jun;45 (6) :1160-1174.|Adv Mater. 2022 Mar;34 (11) :e2108435.|Adv Sci (Weinh) . 2025 Sep 15:e10102.|Am J Pathol. 2023 May;193 (5) :548-557.|Antioxidants (Basel) . 2022 May 20;11 (5) :1003.|bioRxiv. 2024 Jan 7.|BMC Med. 2024 Nov 4;22 (1) :504.|Brain Res Bull. 2024 Jun 1:211:110950.|Cancer Cell Int. 2024 Aug 28;24 (1) :300.|Cancer Cell Int. 2025 Oct 3;25 (1) :328.|Cell Biol Int. 2024 May 5.|Cell Discov. 2024 Nov 12;10 (1) :114.|Cell Metab. 2022 Dec 6;34 (12) :1999-2017.e10.|Cell Rep. 2023 Dec 2;42 (12) :113522.|Cell. 2024 Jun 6;187 (12) :2935-2951.e19.|Cell. 2025 Oct 24:S0092-8674 (25) 01129-8.|ChemMedChem. 2025 Jan 23:e202400913.|Cytotechnology. 2025 Aug;77 (4) :141.|EMBO J. 2025 Aug;44 (15) :4222-4251.|Eur J Pharmacol. 2024 Aug 16:176909.|Exp Cell Res. 2023 Dec 15;433 (2) :113856.|Exp Ther Med. 2023 May 15;26 (1) :318.|FASEB J. 2024 May 31;38 (10) :e23661.|FASEB J. 2025 Jul 15;39 (13) :e70778.|FASEB J. 2025 May 31;39 (10) :e70657.|Front Oncol. 2022 Mar 25;12:773654.|Front Pharmacol. 2025 Sep 29:16:1671461.|Inflammopharmacology. 2025 Jan;33 (1) :257-267.|Int Immunopharmacol. 2025 May 13:158:114807.|Int J Nanomedicine. 2024 Jan 3:19:73-90.|Invest Ophthalmol Vis Sci. 2025 Jun 2;66 (6) :28.|J Biol Chem. 2022 May;298 (5) :101847.|J Cardiovasc Pharmacol. 2022 Sep 1;80 (3) :430-441.|J Cardiovasc Transl Res. 2024 Dec;17 (6) :1415-1426.|J Funct Foods. 2023 Nov , 110, 105823.|J Inflamm Res. 2024 Apr 11:17:2245-2256.|J Inflamm Res. 2024 Jan 9:17:153-170.|J Inflamm Res. 2024 Jul 2:17:4257-4275.|J Med Chem. 2025 Nov 27;68 (22) :24011-24023.|J Mol Neurosci. 2024 Aug 20;74 (3) :79.|J Mol Neurosci. 2025 Oct 14;75 (4) :138.|J Neurochem. 2025 Jan;169 (1) :e16281.|J Neurosci. 2024 Jul 17:e0740242024.|J Periodontal Res. 2024 Aug;59 (4) :798-811.|J Vis Exp. 2025 Oct 3: (224) .|Microbiol Spectr. 2022 Dec 21;10 (6) :e0241022.|Mol Med Rep. 2024 Jul;30 (1) :110.|Mol Med Rep. 2025 Dec;32 (6) :322.|Mol Med. 2024 Sep 12;30 (1) :148.|Nat Commun. 2023 Apr 17;14 (1) :2182.|Neurotherapeutics.2024 May 21:e00377.|Ocul Surf. 2024 Oct:34:406-414.|Open Biol. 2025 Mar;15 (3) :240226.|Patent. US20250127769A1.|Pathol Res Pract. 2025 Sep:273:156143.|Pharmaceuticals (Basel) . 2024 Dec 15;17 (12) :1694.|Phytomedicine. 2022 Mar 21;100:154067.|Phytomedicine. 2025 Oct:146:157130.|Phytother Res. 2022 Feb;36 (2) :938-950.|Phytother Res. 2024 Sep;38 (9) :4386-4405.|Res Sq. 2024 Sep 22.|Res Sq. 2025 Oct 8.|Research Square Preprint. 2023 Oct 13.|Research Square Preprint. 2024 Sep 03.|Research Square Print. 2022 Jun.|SSRN. 2023 Sep 11.|Tissue Cell. 2025 Nov 21:99:103243.|Toxicol Appl Pharmacol. 2026 Jan:506:117655.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Protein Synthesis Initiation Factor 2 alpha (Eukaryotic Translation Initiation Factor 2 alpha, Eukaryotic Translation Initiation Factor 2 Subunit 1 alpha 35kDa, eIF2 alpha, eIF2alpha, eIF-2-alpha, eIF-2alpha, eIF 2a, eIF2a, eIF-2a, CDA02, eIF2S1) (FITC)
P9108-48-FITC 100 µL

Protein Synthesis Initiation Factor 2 alpha (Eukaryotic Translation Initiation Factor 2 alpha, Eukaryotic Translation Initiation Factor 2 Subunit 1 alpha 35kDa, eIF2 alpha, eIF2alpha, eIF-2-alpha, eIF-2alpha, eIF 2a, eIF2a, eIF-2a, CDA02, eIF2S1) (FITC)

Ask
View Details
Human IL16 ELISA kit
55R-2181 96 tests

Human IL16 ELISA kit

Ask
View Details
ACRC (Acidic Repeat-containing Protein) (MaxLight 490)
MBS6199385-01 0.1 mL

ACRC (Acidic Repeat-containing Protein) (MaxLight 490)

Ask
View Details
ACRC (Acidic Repeat-containing Protein) (MaxLight 490)
MBS6199385-02 5x 0.1 mL

ACRC (Acidic Repeat-containing Protein) (MaxLight 490)

Ask
View Details
NCS1 (1-190, His-tag) Human Protein
AR51627PU-S 100 µg

NCS1 (1-190, His-tag) Human Protein

Ask
View Details
Phenylalanine Hydroxylase (PAH, PH, PKU, PKU1) discontinued
212591-01 20 µL

Phenylalanine Hydroxylase (PAH, PH, PKU, PKU1) discontinued

Ask
View Details